A phase 1 study of carfilzomib with rituximab, ifosfamide, carboplatin and etoposide (c‐rice) in transplant‐eligible relapsed/refractory diffuse large b‐cell lymphoma

P. Torka,A. Groman, J. Wong,B. Baysal,J. Nichols, A. Kader,C. Mavis, S. Jani Sait, A. Block, E. Przespolewski, A. Mohr, I. Lund, K. McWhite, J. Kostrewa, J. DeMarco, M. Johnson, A. Darrall, R.‐N. Thomas,S. Sundaram,P. Ghione,A. Hutson, F. Hernandez‐Ilizaliturri

Hematological Oncology(2021)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要